J2KBIO Co., Ltd.

KOSDAQ:A397880 Voorraadrapport

Marktkapitalisatie: ₩164.8b

Kyobo 11 Special Purpose Acquisition Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Kyobo 11 Special Purpose Acquisition has a total shareholder equity of ₩14.1B and total debt of ₩2.4B, which brings its debt-to-equity ratio to 17%. Its total assets and total liabilities are ₩19.9B and ₩5.8B respectively. Kyobo 11 Special Purpose Acquisition's EBIT is ₩3.6B making its interest coverage ratio 14.8. It has cash and short-term investments of ₩5.9B.

Belangrijke informatie

17.0%

Verhouding schuld/eigen vermogen

₩2.40b

Schuld

Rente dekkingsratio14.8x
Contant₩5.90b
Aandelen₩14.08b
Totaal verplichtingen₩5.80b
Totaal activa₩19.88b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Geen updates

Analyse van de financiële positie

Kortlopende schulden: A397880's short term assets (₩13.0B) exceed its short term liabilities (₩5.0B).

Langlopende schulden: A397880's short term assets (₩13.0B) exceed its long term liabilities (₩792.1M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A397880 has more cash than its total debt.

Schuld verminderen: Insufficient data to determine if A397880's debt to equity ratio has reduced over the past 5 years.

Schuldendekking: A397880's debt is well covered by operating cash flow (113.9%).

Rentedekking: A397880's interest payments on its debt are well covered by EBIT (14.8x coverage).


Balans


Ontdek gezonde bedrijven